A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

Clinical trial NCT03518073 · COMPLETED

Trial details

NCT number: NCT03518073
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease (AD)

Start date: 2018-04-30
Primary completion: 2021-08-23
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.